Please select the option that best describes you:
What are your top takeaways from AHA 2024?
Answer from: at Academic Institution
My top three takeaways from the American Heart Association (AHA) 2024 Scientific Sessions:
SUMMIT Trial: Tirzepatide in Heart Failure with Preserved Ejection Fraction (HFpEF)
The SUMMIT trial evaluated the efficacy of tirzepatide, a GLP-1 receptor agonist, in patients with obesity and HFpEF. The...
Sign in or Register to read more